Press Releases

Press Releases




April 5, 2018

Julio Casoy Joins InClinica as Chief Medical Officer of South America

Dr. Casoy has more than 20 years of experience in the pharmaceutical industry, specializing in rheumatology with a long history of work in women’s health. Before joining InClinica, he served as Senior Vice President of Medical Affairs at Turing Pharmaceuticals where he was responsible for establishing and managing medical affairs including data generation, data dissemination, compliance, and KOL management. Prior to that, he oversaw the medical affairs of various pharmaceutical companies, most notably, spending more than a decade leading Wyeth’s international medical affairs in Brazil. [more]

April 3, 2018

Donald L. Very, Jr. Joins InClinica as Chief Technical Analyst, Devices and Diagnostics

Dr. Very has more than 25 years of industry experience in device development, diagnostic and pharmaceutical assay development, and performance qualification in such diverse clinical areas as oncology, infectious disease, and metabolic disease. He is well-versed in each clinical trial step: research, development, performance validation, clinical trial design and implementation, and regulatory approval. [more]

February 5, 2018

InClinica CEO Speaks at the National Conference for Clinical Research in Israel

James Nolan discussed the global clinical trial crisis in Tel Aviv. Nolan’s lecture, titled “The Global Clinical Trial Crisis,” addressed some of the key issues hindering the success of clinical trials. He also offered guidance on how CROs can compete in this continuously changing landscape. [more]